tiprankstipranks
NeoGenomics (NEO)
NASDAQ:NEO
US Market

NeoGenomics (NEO) Financial Statements

Compare
1,827 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently $1.28B. The company's EPS TTM is $-0.622; its P/E ratio is ―; NeoGenomics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 660.57M$ 591.64M$ 509.73M$ 484.33M$ 444.45M
Gross Profit$ 290.10M$ 244.60M$ 187.90M$ 187.06M$ 185.89M
Operating Income$ -92.11M$ -107.74M$ -153.11M$ -9.99M$ -2.13M
EBITDA$ -1.51M$ -17.61M$ -78.63M$ 52.08M$ 34.85M
Net Income$ -78.73M$ -87.97M$ -144.25M$ -8.35M$ 4.17M
Balance Sheet
Cash & Short-Term Investments$ 386.84M$ 415.20M$ 437.99M$ 515.39M$ 296.26M
Total Assets$ 1.64B$ 1.68B$ 1.74B$ 1.87B$ 988.33M
Total Debt$ 605.33M$ 611.68M$ 610.93M$ 612.79M$ 218.22M
Net Debt$ 238.32M$ 269.19M$ 347.75M$ 295.96M$ -10.49M
Total Liabilities$ 735.70M$ 739.69M$ 742.01M$ 761.50M$ 294.04M
Stockholders' Equity$ 902.34M$ 941.54M$ 998.02M$ 1.11B$ 694.29M
Cash Flow
Free Cash Flow$ -34.04M$ -30.70M$ -96.88M$ -90.86M$ -27.64M
Operating Cash Flow$ 7.02M$ -1.95M$ -65.99M$ -26.72M$ 1.46M
Investing Cash Flow$ 12.86M$ 76.71M$ 517.00K$ -632.37M$ -159.44M
Financing Cash Flow$ 4.65M$ 4.55M$ 11.83M$ 725.28M$ 235.60M
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis